These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 34533882)

  • 1. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
    Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
    Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration.
    Zheng Z; Wang B
    Front Immunol; 2021; 12():775526. PubMed ID: 34956204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
    Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
    Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
    Kundi ZM; Lee JC; Pihlajamäki J; Chan CB; Leung KS; So SSY; Nordlund E; Kolehmainen M; El-Nezami H
    Mol Nutr Food Res; 2021 Jan; 65(1):e1900580. PubMed ID: 32526796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gut microbiota in liver regeneration.
    Xu Z; Jiang N; Xiao Y; Yuan K; Wang Z
    Front Immunol; 2022; 13():1003376. PubMed ID: 36389782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
    Singh V; Yeoh BS; Abokor AA; Golonka RM; Tian Y; Patterson AD; Joe B; Heikenwalder M; Vijay-Kumar M
    Gut Microbes; 2020 Jul; 11(4):1077-1091. PubMed ID: 32223398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut microbial metabolites in nonalcoholic fatty liver disease.
    Zhao ZH; Lai JK; Qiao L; Fan JG
    J Dig Dis; 2019 Apr; 20(4):181-188. PubMed ID: 30706694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.
    Kamiya T; Ohtani N
    Int Immunol; 2022 Sep; 34(9):467-474. PubMed ID: 35652367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective.
    Luo L; Chang Y; Sheng L
    Life Sci; 2023 May; 321():121614. PubMed ID: 36965522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The gut-liver axis: how the gut promotes liver disease].
    Demir M; Tacke F
    Inn Med (Heidelb); 2022 Oct; 63(10):1028-1035. PubMed ID: 36053302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.
    Pallozzi M; De Gaetano V; Di Tommaso N; Cerrito L; Santopaolo F; Stella L; Gasbarrini A; Ponziani FR
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
    Ji Y; Yin Y; Li Z; Zhang W
    Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
    Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
    Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.